Search research articles
Contact Us
Filters
Showing results (11-20 of 111) with videos related to
Page
of 12
Sort By:
Molecular Microbiology
|
November 19, 2016
EspC forms a filamentous structure in the cell envelope of Mycobacterium tuberculosis and impacts ESX-1 secretion
Ye Lou, Jan Rybniker, Claudia Sala, et al.
STAR Protocols
|
November 9, 2024
Protocol for developing Pseudomonas aeruginosa type III secretion system-neutralizing monoclonal antibodies from human B cells
Alexandra Albus, Christoph Kreer, Florian Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2019
Combination Antimicrobial Therapy for Enterococcus faecalis Infective Endocarditis
Philipp Koehler, Norma Jung, Oliver A Cornely, et al.
Frontiers in Pharmacology
|
June 20, 2022
<i>In vitro</i> Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant <i>Mycobacterium tuberculosis</i>
Ada Marie Hoffmann, Martina Wolke, Jan Rybniker, et al.
Clinical Microbiology Reviews
|
October 15, 2020
Remdesivir against COVID-19 and Other Viral Diseases
Jakob J Malin, Isabelle Suárez, Vanessa Priesner, et al.
Journal of Global Antimicrobial Resistance
|
February 26, 2023
Activity of the old antimicrobial nitroxoline against Mycobacterium abscessus complex isolates
Ada Marie Hoffmann, Martina Wolke, Jan Rybniker, et al.
Microbiology (Reading, England)
|
August 1, 2008
Identification of three cytotoxic early proteins of mycobacteriophage L5 leading to growth inhibition in Mycobacterium smegmatis
Jan Rybniker, Georg Plum, Nirmal Robinson, et al.
Innere Medizin (Heidelberg, Germany)
|
January 19, 2026
[Positive interferon-gamma release assay and immunosuppression: guideline-based diagnosis and treatment of tuberculosis infection]
Carola Horn-Magar, Jonathan Steinke, Philipp Köhler, et al.
EMBO Molecular Medicine
|
October 5, 2020
A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2
Alexander Simonis, Sebastian J Theobald, Gerd Fätkenheuer, et al.
Traffic (Copenhagen, Denmark)
|
September 4, 2008
Mycobacterial phenolic glycolipid inhibits phagosome maturation and subverts the pro-inflammatory cytokine response
Nirmal Robinson, Thomas Kolter, Martina Wolke, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 111) with videos related to
Sort By:
Page
of 12
Molecular Microbiology
|
November 19, 2016
EspC forms a filamentous structure in the cell envelope of Mycobacterium tuberculosis and impacts ESX-1 secretion
Ye Lou, Jan Rybniker, Claudia Sala, et al.
STAR Protocols
|
November 9, 2024
Protocol for developing Pseudomonas aeruginosa type III secretion system-neutralizing monoclonal antibodies from human B cells
Alexandra Albus, Christoph Kreer, Florian Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2019
Combination Antimicrobial Therapy for Enterococcus faecalis Infective Endocarditis
Philipp Koehler, Norma Jung, Oliver A Cornely, et al.
Frontiers in Pharmacology
|
June 20, 2022
<i>In vitro</i> Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant <i>Mycobacterium tuberculosis</i>
Ada Marie Hoffmann, Martina Wolke, Jan Rybniker, et al.
Clinical Microbiology Reviews
|
October 15, 2020
Remdesivir against COVID-19 and Other Viral Diseases
Jakob J Malin, Isabelle Suárez, Vanessa Priesner, et al.
Journal of Global Antimicrobial Resistance
|
February 26, 2023
Activity of the old antimicrobial nitroxoline against Mycobacterium abscessus complex isolates
Ada Marie Hoffmann, Martina Wolke, Jan Rybniker, et al.
Microbiology (Reading, England)
|
August 1, 2008
Identification of three cytotoxic early proteins of mycobacteriophage L5 leading to growth inhibition in Mycobacterium smegmatis
Jan Rybniker, Georg Plum, Nirmal Robinson, et al.
Innere Medizin (Heidelberg, Germany)
|
January 19, 2026
[Positive interferon-gamma release assay and immunosuppression: guideline-based diagnosis and treatment of tuberculosis infection]
Carola Horn-Magar, Jonathan Steinke, Philipp Köhler, et al.
EMBO Molecular Medicine
|
October 5, 2020
A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2
Alexander Simonis, Sebastian J Theobald, Gerd Fätkenheuer, et al.
Traffic (Copenhagen, Denmark)
|
September 4, 2008
Mycobacterial phenolic glycolipid inhibits phagosome maturation and subverts the pro-inflammatory cytokine response
Nirmal Robinson, Thomas Kolter, Martina Wolke, et al.
Page
of 12